Title
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma
Document Type
Article
Date of Publication
2017
Publication Title
Neuro-Oncology
First Page
1469
Last Page
1480
DOI
https://doi.org/10.1093/neuonc/nox044
Recommended Citation
McNeill, R. S.; Canoutas, D. A.; Stuhlmiller, T. J.; Dhruv, H. D.; Irvin, D. M.; Bash, R. E.; Angus, S. P.; Herring, L. E.; Simon, J. M.; Skinner, K. R.; Limas, J. C.; Chen, X.; Schmid, R. S.; Siegel, M. B.; Van Swearingen, A. E.; Hadler, M. J.; Sulman, E. P.; Sarkaria, J. N.; Anders, C. K.; Graves, L. M.; Berens, M. E.; Johnson, G. L.; and Miller, C. R., "Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma" (2017). Pharmaceutical Sciences. 2328.
https://cufind.campbell.edu/pharmacy/2328
